Our CEO Kevin Hrusovsky joined Lyanne Alfaro on set of Nasdaq's
Resources by Therapeutic Area
Chen Y, Cai Q and Liu S Anal Biochem. 2019 Sep 30;587:113467. doi: 10.1016/j.ab.2019.113467.
Cohen L, Keegan A and Walt DR
Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration‐resistant prostate cancer
George DJ, Halabi S, Healy P, Barak I, Winters C, Anand M, Wilder R, Klein M, Martinez E, Nixon AB, Harrison MR, Szmulewitz R and Armstrong AJ